You are here

  • Home
  • Archive
  • Volume 65, Issue 2
  • Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Citation Tools

Article menu
XML
Hepatology
Original article
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Fan R, Sun J, Yuan Q Chronic Hepatitis B Study Consortium, et al
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
Gut 2016;65:313-320.